CoChat

Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer

Open access

The DOI matches its Crossref record; 49 of the 51 references it cites were found in a registry or an index.

Abstract

Objectives: Autophagy plays a dual role in tumorigenesis. In the initial stages, it promotes cell survival and suppresses carcinogenesis, whereas in cancer development, it induces cancer cell survival. In this study, we investigate the role of autophagy as a protective or tumor suppressor mechanism in colorectal cancer (CRC) cell lines and evaluate its role as a potential biomarker in human tumor samples. Materials and Methods: The data of 68 patients with CRC treated at our Department from January 1 to December 31, 2016 were analyzed. Immunohistochemistry evaluation of p62, LC3B, Beclin-1, and Rab-7 in formalin-fixed paraffin-embedded tissue samples was performed and their expression was correlated with clinicopathologic characteristics, mutation status, and therapeutic approach. The χ 2 was used to test an association among categorical variables. Survival curves were estimated using the Kaplan-Meier method and differences were assessed using the log-rank test. Colo-205, HT29, SW-480, and Caco-2 cell lines were also used so as to test the autophagy markers with oxaliplatin, irinotecan, hydroxychloroquine, and 3-methyladenine. Results: Overexpression of Beclin-1 is associated with poor survival (P=0.001) in patients with CRC treated with chemotherapy, irrespective of the stage and mutational status. Rab-7 is also correlated with progression-free survival (PFS) (P=0.088). Oxaliplatin (10 and 20 μΜ) and irinotecan (10 and 20 μΜ) inhibit autophagy in microsatellite stable (MSS) CRC cell lines. The inhibition of autophagy in MSS CRC cell lines after treatment with oxaliplatin and irinotecan is further identified through monodancylcadaverine staining. Moreover, inhibition of autophagy with molecules such as hydroxychloroquine (20 μΜ) and 3-methyladenine (5 mM) was identified by the accumulation of p62 and LC3B. Conclusions: Beclin-1 is an independent prognostic factor of overall survival and PFS. Also, Rab-7 is identified as an independent prognostic factor of PFS. Besides, several chemotherapeutic drugs such as oxaliplatin and irinotecan inhibit autophagy in MSS CRC cell lines in a similar way like hydroxychloroquine and 3-methyladenine. Thus, in MSS patients who develop chemoresistance, a combination of other therapies that include an autophagy inhibitor could be more beneficial. Further clinical trials are needed to investigate these therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/coc.0000000000000592

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Immunohistochemical staining of p62, LC3B, Beclin-1, and Rab-7 in human colorectal carcinomas (×40).
FIGURE 1 Immunohistochemical staining of p62, LC3B, Beclin-1, and Rab-7 in human colorectal carcinomas (×40).CC BY-NC-ND · PubMed Central
FIGURE 2 A, Kaplan-Meier estimates of overall survival of patients with CRC with low and high expression of autophagy markers p62, LC3B, Beclin-1, and Rab-7. High expression of Beclin-1 reduces life span. B, Kaplan-Meier estimates of PFS of patients with CRC with low and high expression of autophagy markers p62, LC3B, Beclin-1, and Rab-7. In low expression of Beclin-1 and Rab-7, we observed better PFS. CRC indicates colorectal cancer; PFS, progression-free survival.
FIGURE 2 A, Kaplan-Meier estimates of overall survival of patients with CRC with low and high expression of autophagy markers p62, LC3B, Beclin-1, and Rab-7. High expression of Beclin-1 reduces life span. B, Kaplan-Meier estimates of PFS of patients with CRC with low and high expression of autophagy markers p62, LC3B, Beclin-1, and Rab-7. In low expression of Beclin-1 and Rab-7, we observed better PFS. CRC indicates colorectal cancer; PFS, progression-free survival.CC BY-NC-ND · PubMed Central
FIGURE 3 Oxaliplatin and irinotecan inhibit autophagy in microsatellite stable colorectal cancer cell lines. Western blot analysis after 24-hour exposure of cells in 10 and 20 μM of oxaliplatin or irinotecan. The protein levels of Beclin-1, p62, LC3, and Rab-7 were identified by specific antibody. The quantification of LC3 reflects the whole protein levels as compared with the untreated sample in each cell line (i) and the ratio of LC3II/LC3I in each sample separately (ii). Protein levels were normalized against actin (A). The formation of autophagic vacuoles in Caco-2, Colo-205, HT29, and SW-480 cells because of treatments was determined with 0.1 mM of MDC (light blue) through confocal microscopy, whereas phalloidin staining (red) was used for cytoskeleton detection. The yellow arrows show the autophagic vacuoles. The graph represents the quantification of MDC in each cell line (B). MDC indicates monodansylcadaverine.
FIGURE 3 Oxaliplatin and irinotecan inhibit autophagy in microsatellite stable colorectal cancer cell lines. Western blot analysis after 24-hour exposure of cells in 10 and 20 μM of oxaliplatin or irinotecan. The protein levels of Beclin-1, p62, LC3, and Rab-7 were identified by specific antibody. The quantification of LC3 reflects the whole protein levels as compared with the untreated sample in each cell line (i) and the ratio of LC3II/LC3I in each sample separately (ii). Protein levels were normalized against actin (A). The formation of autophagic vacuoles in Caco-2, Colo-205, HT29, and SW-480 cells because of treatments was determined with 0.1 mM of MDC (light blue) through confocal microscopy, whereas phalloidin staining (red) was used for cytoskeleton detection. The yellow arrows show the autophagic vacuoles. The graph represents the quantification of MDC in each cell line (B). MDC indicates monodansylcadaverine.CC BY-NC-ND · PubMed Central
FIGURE 4 The protein levels of autophagy markers after treatment with 5 mM of 3-MA and 20 μM of HCQ in colorectal cancer cell lines. Western blot analysis after 24-hour exposure of cells in 5 mM of 3-MA and 20 μM of HCQ. The protein levels of Beclin-1, p62, LC3, and Rab-7 are presented. The quantification of LC3 reflects the whole protein levels as compared with the untreated sample in each cell line (i) and the ratio of LC3II/LC3I in each sample separately (ii). Protein levels were normalized against actin. HCQ indicates hydroxychloroquine; 3-MA, 3-methyladenine.
FIGURE 4 The protein levels of autophagy markers after treatment with 5 mM of 3-MA and 20 μM of HCQ in colorectal cancer cell lines. Western blot analysis after 24-hour exposure of cells in 5 mM of 3-MA and 20 μM of HCQ. The protein levels of Beclin-1, p62, LC3, and Rab-7 are presented. The quantification of LC3 reflects the whole protein levels as compared with the untreated sample in each cell line (i) and the ratio of LC3II/LC3I in each sample separately (ii). Protein levels were normalized against actin. HCQ indicates hydroxychloroquine; 3-MA, 3-methyladenine.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 49 references

Cited by

See all 44

Metadata

Authors
Koustas, E., Sarantis, P., Theoharis, S., Saetta, A. A., Chatziandreou, I., Kyriakopoulou, G., Giannopoulou, I., Michelli, M., Schizas, D., Papavassiliou, A. G., & Karamouzis, M. V.
Affiliations
  • Molecular Oncology Unit, Department of Biological Chemistry
  • Department of Pathology
  • First Department of Surgery
  • National and Kapodistrian University of Athens (GR)
Corresponding author
  • Koustas, Evangelos
  • Sarantis, Panagiotis
  • Kyriakopoulou, Georgia
  • Papavassiliou, Athanasios G.
  • Karamouzis, Michalis V.
Venue
American Journal of Clinical Oncology
Published
2019-10
Volume
42
Issue
10
Pages
767-776
ISSN
0277-3732 (ISSN-L)
OpenAlex
W2972837098
Cited by
44
References
51
Citations by year
2026: 4 · 2025: 6 · 2024: 12 · 2023: 5 · 2022: 8 · 2021: 4 · 2020: 5
FWCI
3.24
Type
journal article
Language
en
Open access
Locations
  • American Journal of Clinical Oncology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
Keywords
colorectal cancer, autophagy, prognostic factors, Beclin-1, Rab7, p62, LC3B, oxaliplatin, irinotecan, hydroxychloroquine, 3-methyladenine, microsatellite stable, tumor suppressor, overall survival, progression-free survival, autophagy inhibition, chemotherapy response, KRAS
MeSH terms
Autophagy-Related Proteins, Beclin-1, Adult, Aged, Aged, 80 and over, Biopsy, Needle, Combined Modality Therapy, Female, Humans, Immunohistochemistry, Male, Middle Aged, Mutation, Prognosis, Retrospective Studies, Biomarkers, Tumor, Colorectal Neoplasms, Cohort Studies, Survival Analysis, Disease-Free Survival, Statistics, Nonparametric, Cell Line, Tumor, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer. https://app.cochat.ai/papers/10.1097/coc.0000000000000592
The paper
Koustas, E., Sarantis, P., Theoharis, S., Saetta, A. A., Chatziandreou, I., Kyriakopoulou, G., Giannopoulou, I., Michelli, M., Schizas, D., Papavassiliou, A. G., & Karamouzis, M. V. (2019). Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer. American Journal of Clinical Oncology. https://doi.org/10.1097/coc.0000000000000592

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.